AYTU BIOPHARMA, INC License and Maintenance Revenue (Deprecated 2018-01-31)
AYTU BIOPHARMA, INC (AYTU) reported License and Maintenance Revenue (Deprecated 2018-01-31) of $0 for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndMaintenanceRevenue · last filed 2017-05-11
- AYTU BIOPHARMA, INC license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC license and maintenance revenue (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $21.00K, a 67.19% decline year-over-year.
| Period end | License and Maintenance Revenue (Deprecated 2018-01-31) 3 month | License and Maintenance Revenue (Deprecated 2018-01-31) 6 month | License and Maintenance Revenue (Deprecated 2018-01-31) 6 month as first filed | License and Maintenance Revenue (Deprecated 2018-01-31) 9 month | License and Maintenance Revenue (Deprecated 2018-01-31) 9 month as first filed |
|---|---|---|---|---|---|
| 2017-03-31 | $0.00 10-Q · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-05-11 | $0.00 10-Q · filed 2017-05-11 | ||
| 2016-12-31 | $0.00 10-Q · filed 2017-02-09 | $0.00 10-Q · filed 2017-02-09 | |||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | ||||
| 2016-03-31 | $21.00K 10-Q · filed 2017-05-11 | $42.00K derived: sum of 2 quarters · filed 2017-05-11 | $64.00K 10-Q · filed 2017-05-11 | $21.00K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $21.00K 10-Q · filed 2017-02-09 | $43.00K 10-Q · filed 2017-02-09 | $21.00K 10-Q · filed 2016-02-11 | ||
| 2015-09-30 | $21.00K 10-Q · filed 2016-11-07 | ||||
| 2015-03-31 | $64.00K 10-Q · filed 2016-05-11 | $64.00K 10-Q · filed 2016-05-11 | |||
| 2014-12-31 | $43.00K 10-Q · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |